Opens in a new tab

Dr. Wang Jianping

Chinese name: 汪建平
Professor, Chief Physician, Doctoral Supervisor, Postdoctoral Co-supervisor . Colorectal Surgery
Dr. Wang Jianping is Honorary President and Chief Expert in colorectal surgery at the Sixth Affiliated Hospital of Sun Yat-sen University and a former Executive Vice President of Sun Yat-sen University. A Fellow of the Royal College of Surgeons of England, he helped pioneer laparoscopic colorectal cancer surgery in China.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

30+
Years in clinical practice
30+
SCI publications
2
Guangdong S&T Progress Award, First Class

  • The Physician

About Dr. Wang Jianping

Dr. Wang Jianping is Honorary President and Chief Expert in colorectal surgery at the Sixth Affiliated Hospital of Sun Yat-sen University, and a former Executive Vice President of Sun Yat-sen University. He has devoted more than forty years to general and colorectal surgery, with particular expertise in sphincter-preserving surgery for ultra-low rectal cancer, locally recurrent rectal cancer, retroperitoneal tumours and Crohn's disease. As a Fellow of the Royal College of Surgeons of England and the American College of Surgeons, he helped introduce laparoscopic colorectal cancer surgery in China. He co-led the Chinese colorectal cancer treatment guidelines and co-authored national surgery textbooks, and his research won the Second Class National Science and Technology Progress Award.
1、Honorary President and Chief Expert in colorectal surgery at the Sixth Affiliated Hospital of Sun Yat-sen University
2、Former Executive Vice President of Sun Yat-sen University and first President of the Sixth Affiliated Hospital
3、Fellow of the Royal College of Surgeons of England and the American College of Surgeons
4、Recipient of the State Council Special Allowance and the Ministry of Health Young and Middle-aged Expert with Outstanding Contributions award
5、Co-chair of the expert group for the Chinese Colorectal Cancer Treatment Guidelines and co-editor-in-chief of the national Surgery textbook
6、Recipient of the Second Class National Science and Technology Progress Award and two First Class Guangdong Science and Technology Progress Awards

Dr. Wang Jianping ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Colorectal cancer

He has performed colorectal cancer surgery for more than four decades, specialising in radical resection with total mesorectal excision and nerve preservation so that patients achieve durable tumour control while retaining bowel, urinary and sexual function after treatment in everyday clinical practice.

Sphincter-preserving surgery

He is known for sphincter-preserving operations in ultra-low rectal cancer, using careful pelvic dissection and intersphincteric techniques to remove the tumour completely while avoiding a permanent stoma, so that patients keep normal anal function and a better quality of life.

Complex and recurrent colorectal cancer

He manages locally advanced, recurrent and metastatic colorectal cancer, combining surgery for pelvic recurrence, retroperitoneal tumours and liver metastases with multidisciplinary treatment, so that patients with difficult disease still receive complete, coordinated and evidence-based care together with the newest targeted and immune therapies.

More： Crohn’s disease——surgical treatment; inflammatory bowel disease——multidisciplinary care; ileal pouch surgery——restorative proctocolectomy; retroperitoneal tumour——resection; colorectal cancer screening——early detection

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Transanal vs Laparoscopic Total Mesorectal Excision (TaLaR Trial, 3-Year Results)
A multicenter randomized trial compared transanal total mesorectal excision (taTME) with laparoscopic TME for rectal cancer in 1,114 patients across 16 Chinese hospitals. Three-year disease-free survival was 82.1% with taTME versus 79.4% with laparoscopy, showing non-inferior oncologic safety for patients seeking sphincter-preserving rectal cancer surgery.
2. TaLaR Short-Term Surgical Outcomes (Annals of Surgery 2023)
This report presented short-term results of the TaLaR study, evaluating pelvic dissection quality, circumferential resection margin status, and postoperative recovery after transanal total mesorectal excision for low rectal cancer. The findings supported this anal-preserving minimally invasive approach for difficult mid and low rectal cancer surgery in China.
3. FOWARC Trial: Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer
The FOWARC randomized trial of 495 rectal cancer patients compared modified FOLFOX6 with or without radiation against standard chemoradiotherapy before surgery. It examined organ-preservation and tumor-downstaging strategies, informing modern neoadjuvant treatment choices for patients with locally advanced rectal cancer who wish to avoid radiotherapy.
4. First International Multicenter TaTME Trial Led by a Chinese Colorectal Team
According to Sun Yat-sen University news, the TaLaR trial was reported as the first international multicenter randomized study of transanal total mesorectal excision for rectal cancer, coordinated across 16 tertiary hospitals. It provided global evidence for patients considering transanal sphincter-preserving surgery.
5. JAMA 2025 Report on TaTME for Rectal Cancer
Published in JAMA, the trial found that transanal total mesorectal excision achieved three-year disease-free survival comparable to laparoscopic TME among 1,114 rectal cancer patients. The result reassured surgeons that the transanal approach is oncologically safe, supporting its use for difficult low rectal cancer.
6. Senior Colorectal Surgeon Profile: Rectal and Colon Cancer Surgery
The official profile summarizes decades of experience in colorectal cancer surgery, including sphincter-preserving procedures for low rectal cancer, multidisciplinary management of complex colorectal tumors, inflammatory bowel disease, and anorectal disorders, helping patients locate authoritative clinical care for colorectal cancer in Guangzhou.
  • Affiliated Hospital

Where Dr. Wang Jianping practices

Guangzhou

The Sixth Affiliated Hospital, Sun Yat-sen University

Chinese name: 中山大学附属第六医院
Founded in 1964, Sun Yat-sen University Sixth Affiliated Hospital is a Grade-A tertiary hospital renowned for gastrointestinal surgery and reproductive medicine, holding 3 national key specialties and the world's largest IBD case volume, opening 1,497 beds and ranking A+ nationally.
Since 1964
62 years of care
1,497
Licensed beds
6,415
Colorectal surgeries (2024)
1.66 million
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Wang Jianping?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Wang Jianping.